LAB Research enters into new agency agreement to extend its Korean market
coverage
Second exclusive Asian market agency agreement signed following proven commercial success of Japanese agreement
LAVAL, QC,
Under the terms of the agreement, Safe Chemicals has been granted exclusive representation rights to promote LAB Research and its complete service offering to the chemical and agrochemical markets in Korea. In addition, Safe Chemical will also be granted non-exclusive rights to service the pharmaceutical and other Korean markets. This agency agreement will accelerate the commercialization of LAB Research Hungary's services to a targeted Korean clientele while also helping to promote the expanded service offering of each of LAB Research
"Following the proven and growing commercial success of our Japanese agency agreement, we are very pleased to partner with Safe Chemicals to promote our expanded capabilities and service offering to the Korean market. We believe Safe Chemical has the right reputation, expertise and market knowledge to truly help promote LAB Research's services to the local chemical and agrochemical clientele. By combining the efforts of Safe Chemical and Eastern Trading we hope to increase the awareness of the LAB Research brand in Korea and also help sustain a presence in each of its local market segments. We hope to replicate in Korea, the success we have reached in
About Safe Chemicals Co., LTD
Safe Chemicals Co., Ltd., based in
About LAB Research Inc.:
LAB Research is a Canadian global non-clinical contract research organization that provides contract research services to the pharmaceutical, biotechnology, agro-chemical, petro-chemical and industrial markets. LAB Research supports the development of its customers' products from three state-of-the-art facilities located in
LAB Research's shares trade on the TSX under the symbol "LRI", with 18.1 million shares outstanding.
This news release contains certain forward-looking statements that reflect the current views and/or expectations of LAB Research Inc. with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly.
%SEDAR: 00023798EF
For further information: visit LAB Research's website at www.labresearch.com, or contact: Luc Mainville, Chief Executive Officer, (450) 973-2240 (ext. 1206), [email protected]; Frédéric Dumais, Partner, Jasmin-Dumais Financial Communications, (514) 862-1251, [email protected]
Share this article